Press Releases Year None2022202120202019201820172015 May 17, 2022 ORIC Pharmaceuticals to Present at the H.C. Wainwright Global Investment Conference May 9, 2022 ORIC Pharmaceuticals Reports First Quarter 2022 Financial Results and Operational Update April 12, 2022 ORIC Pharmaceuticals Presents Promising Preclinical Data on Three Programs at the 2022 American Association for Cancer Research (AACR) Annual Meeting March 21, 2022 ORIC Pharmaceuticals Reports Fourth Quarter and Full Year 2021 Financial Results and Operational Update March 17, 2022 ORIC Pharmaceuticals to Host Fourth Quarter and Full Year 2021 Financial Results and Operational Update Conference Call March 8, 2022 ORIC Pharmaceuticals Announces Multiple Presentations at the 2022 American Association for Cancer Research (AACR) Annual Meeting February 2, 2022 ORIC Pharmaceuticals to Participate in the Guggenheim 2022 Oncology Conference January 25, 2022 ORIC Pharmaceuticals Announces Regulatory Clearance of Clinical Trial Application for ORIC-114 in Advanced Solid Tumors with EGFR or HER2 Exon 20 Alterations or HER2 Amplifications January 10, 2022 ORIC Pharmaceuticals Provides Corporate Update and Highlights Key Upcoming Milestones January 4, 2022 ORIC Pharmaceuticals to Present at the 40th Annual J.P. Morgan Healthcare Conference
